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Abstract This study aimed to investigate the metastable zone
width (MSZW) and the nucleation order of carbamazepine–
saccharin (CBZ–SAC) co-crystals via slow cooling crys-
tallisation, to obtain the kinetic value using Kashchiev–Bor-
issova–Hammond–Roberts (KBHR) technique and to deduce
the induction time, the radius of the critical nucleus and the
interfacial energy of the CBZ–SAC co-crystals via fast cool-
ing. Slow cooling experiments with cooling/heating rates of
0.8, 0.6, 0.4 and 0.2 C min-1 were applied to determine the
crystallisation and the dissolution temperature of CBZ–SAC
co-crystals at SAC:CBZ ratios of (3.5, 3.0, 2.5, 2.0 and 1.0)
and CBZ concentrations of 19.14, 17.96, 17.06 and
15.83 mg mL-1. Then, fast cooling experiments were run at
CBZ concentration of 17.96 mg mL-1 and SAC:CBZ mole
ratio of 2.0. Nucleation kinetics, such as MSZW, nucleation
order, nucleation kinetic constant and interfacial energy, was
determined and analysed. KBHR method was applied to
analyse the kinetics value and compared with isothermal
method. The nucleation orders obtained from slow cooling
method were in between 1.65 and 4.9, which were within the
range for nucleation of organic compounds. The results of
KBHRmethod in determining the kinetic values of CBZ–SAC
co-crystals were similar to those of the isothermal method.
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Introduction
Metastable zone is the area between solubility and super-
solubility curves, where a solution is supersaturated and
spontaneous crystallisation is unlikely to occur. This region
is vital for crystallisation process because the supersaturation
can be controlled within this region to obtain the desired
crystal properties. The optimisation of a crystallisation pro-
cess and the quality of the formed crystal can be controlled
when the crystallisation occurs within the metastable zone
[1, 2]. The factors affecting the metastable zone width
(MSZW) are cooling/heating rates, solution temperature,
impurities or seeds, stirring rate, and solvent [3–5].
In the recent decade, co-crystal has been one of the
major interesting research subjects due to its ability to
enhance the physicochemical properties of active phar-
maceutical ingredients (APIs), such as solubility, stabil-
ity, dissolution rate, bioavailability and compressibility
[6–8]. Co-crystals are defined as ‘‘solids that are crys-
talline single-phase materials composed of two or more
different molecular and/or ionic compounds generally in
a stoichiometric ratio which are neither solvates nor
simple salts’’ [9]. Co-crystal is known as pharmaceutical
co-crystal when one of the co-formers is an API [8, 10].
In pharmaceutical industry, the physicochemical proper-
ties of the API play an important role to ensure that the
drug is a cost-effective, safe and efficient [11–13]. The
study of kinetics and nucleation mechanism is surely
important in designing and controlling of the shape and
size of the final crystalline product. Therefore, by
understanding the fundamental of co-crystal nucleation
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